Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pietra

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Expert Review of Hematology|June 5, 2018
Diagnosis and management of prefibrotic myelofibrosisElisa Rumi, Emanuela Sant'Antonio, Emanuela Boveri, et al.
Leukemia Research|May 2, 2017
Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of HematologyPaola Guglielmelli, Daniela Pietra, Fabrizio Pane, et al.
American Journal of Hematology|September 10, 2025
CHEK2 Germline Variants in Early-Onset and Familial Myeloproliferative NeoplasmsOscar Borsani, Elisabetta Molteni, Daniela Pietra, et al.
Case Reports in Oncology|December 1, 2025
A New t(8;9) Translocation Involving the JAK2 Gene in Acute Myeloid Leukemia: A Case ReportSilvia Catricalà, Irene Dambruoso, Marina Boni, et al.
Haematologica|October 2, 2010
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSSChiara Elena, Francesco Passamonti, Elisa Rumi, et al.
American Journal of Hematology|September 9, 2014
Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasmsRoland Jäger, Ashot S Harutyunyan, Elisa Rumi, et al.
Haematologica|November 27, 2010
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patientsElisa Rumi, Francesco Passamonti, Chiara Elena, et al.
Blood|April 3, 2010
Validation of cytogenetic-based risk stratification in primary myelofibrosisElisa Rumi, Francesco Passamonti, Paolo Bernasconi, et al.
Experimental Hematology|November 8, 2023
Germline MPL mutations may be a rare cause of "triple-negative" thrombocytosisOscar Borsani, Daniela Pietra, Ilaria Carola Casetti, et al.
Research and Practice in Thrombosis and Haemostasis|March 31, 2023
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasmsOscar Borsani, Virginia V Ferretti, Ilaria C Casetti, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Expert Review of Hematology|June 5, 2018
Diagnosis and management of prefibrotic myelofibrosisElisa Rumi, Emanuela Sant'Antonio, Emanuela Boveri, et al.
Leukemia Research|May 2, 2017
Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of HematologyPaola Guglielmelli, Daniela Pietra, Fabrizio Pane, et al.
American Journal of Hematology|September 10, 2025
CHEK2 Germline Variants in Early-Onset and Familial Myeloproliferative NeoplasmsOscar Borsani, Elisabetta Molteni, Daniela Pietra, et al.
Case Reports in Oncology|December 1, 2025
A New t(8;9) Translocation Involving the JAK2 Gene in Acute Myeloid Leukemia: A Case ReportSilvia Catricalà, Irene Dambruoso, Marina Boni, et al.
Haematologica|October 2, 2010
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSSChiara Elena, Francesco Passamonti, Elisa Rumi, et al.
American Journal of Hematology|September 9, 2014
Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasmsRoland Jäger, Ashot S Harutyunyan, Elisa Rumi, et al.
Haematologica|November 27, 2010
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patientsElisa Rumi, Francesco Passamonti, Chiara Elena, et al.
Blood|April 3, 2010
Validation of cytogenetic-based risk stratification in primary myelofibrosisElisa Rumi, Francesco Passamonti, Paolo Bernasconi, et al.
Experimental Hematology|November 8, 2023
Germline MPL mutations may be a rare cause of "triple-negative" thrombocytosisOscar Borsani, Daniela Pietra, Ilaria Carola Casetti, et al.
Research and Practice in Thrombosis and Haemostasis|March 31, 2023
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasmsOscar Borsani, Virginia V Ferretti, Ilaria C Casetti, et al.
Pageof 10